- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Luke Bosso
Insights 13 results
Client Alert
May 19, 2023
FDA Releases Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol
Article · Source: FDLI's Update Magazine
March 30, 2023
Product Testing, Questionable Science, and the Smallest, Big Developments in Consumer Product Litigation
Newsletter
December 20, 2022
Chemical Currents – December 20, 2022
Newsletter
September 29, 2022
Chemical Currents – September 29, 2022
Newsletter
June 30, 2022
Chemical Currents – June 30, 2022
Newsletter
April 18, 2022
Chemical Currents – April 18, 2022
Newsletter
March 10, 2022
Chemical Currents – March 10, 2022
Article · Source: IADC’s Defense Counsel
January 26, 2022
Taking a “Hard Look” at Expert Witness Testimony Under Rule 702
Newsletter
January 25, 2022
Chemical Currents – January 25, 2022
Client Alert
January 4, 2022
FDA Alerts Pharmaceutical Manufacturers to Risk of Benzene in Certain Drugs
Newsletter
December 13, 2021
Chemical Currents – December 13, 2021
Newsletter
November 2, 2021
Chemical Currents - November 2, 2021